The U.S. government is continuing its push to accelerate biomanufacturing innovation, including with a Department of Defense biomanufacturing strategy released in March 2023. Recent policy and strategy updates aim to guide investments and research across the U.S. government and private sector. 

This comes at a crucial moment. New technologies mean that biotech will play an increasingly influential role across a range of sectors—including how states prepare for and respond to biological risks.

On May 16 at 12:00pm ET, the Council on Strategic Risks will host a public event focused on this critical area of progress in U.S. resilience. We are thrilled to welcome the following key leaders in the U.S. effort to accelerate biotechnology and biomanufacturing innovation:  

• Dr. Georgia Lagoudas, Senior Adviser for Biotechnology and Bioeconomy at the White House Office of Science and Technology Policy
• Maynard Holliday, Deputy Chief Technology Officer for Critical Technologies at the U.S. Department of Defense
• Anup Singh, Associate Director for Engineering, Lawrence Livermore National Laboratory
• Christine Parthemore (moderator), Chief Executive Officer, Council on Strategic Risks

Other speakers to be confirmed soon.

Attend this event

This event will be held in-person at The Darcy Hotel in Washington, D.C. CSR will also record the discussion and release a version on our website shortly following the event. RSVP to attend here.